{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T08:46:30Z","timestamp":1794818790077,"version":"4.9.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1067\/mhj.2001.113994","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T17:24:11Z","timestamp":1034184251000},"page":"566-572","source":"Crossref","is-referenced-by-count":40,"title":["Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin"],"prefix":"10.1067","volume":"141","author":[{"given":"Jose","family":"Santopinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique P.","family":"Gurfinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo E.","family":"Bozovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branco","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn H.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott M.","family":"Antman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2001.113994_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (1)","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.113994_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (2)","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.113994_bib3","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.CIR.80.6.1501","article-title":"Antithrombotic therapy in cardiac disease: an emerging approach based on pathogenesis and risk","volume":"80","author":"Stein","year":"1989","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.113994_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1067\/mhj.2001.113994_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","author":"RISC Group","year":"1990","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.113994_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.97.12.1195","article-title":"Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction","volume":"97","author":"Theroux","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.113994_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0735-1097(98)00601-9","article-title":"A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials","volume":"33","author":"Folts","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2001.113994_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder: a pilot-study including 180 post-stroke patients","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thromb Res"},{"key":"10.1067\/mhj.2001.113994_bib9","unstructured":"Farrel TP, Hayes KA, Tracy PB, et al. Unexpected, discordant effects of aspirin on platelet reactivity [abstract 871-1]. Proceedings of the American College of Cardiology Scientific Sessions; 1988 March; Atlanta, Georgia. Atlanta: The College; 1988."},{"key":"10.1067\/mhj.2001.113994_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.113994_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/hj.1999.v137.93029","article-title":"Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3","volume":"137","author":"Bazzino","year":"1999","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2001.113994_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.113994_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomized trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"BMJ"},{"key":"10.1067\/mhj.2001.113994_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(97)11162-X","volume":"352","author":"Yusuf","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mhj.2001.113994_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1053\/euhj.1999.1836","article-title":"Specific antithrombins in the context of current treatment for acute coronary syndromes","volume":"20","author":"Fox","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2001.113994_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"10.1067\/mhj.2001.113994_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"The Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group: a comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.113994_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0002-8703(00)90090-5","article-title":"Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions","volume":"139","author":"Antman","year":"2000","journal-title":"Am Heart J"},{"issue":"Suppl","key":"10.1067\/mhj.2001.113994_bib19","first-page":"N18","article-title":"Prior aspirin use in unstable coronary syndromes results in a lower incidence of non-Q-wave MI but a higher rate of medical therapy failure with unfractionated heparin: the aspirin paradox","volume":"100","author":"Lancaster","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2001.113994_bib20","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","author":"Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms PRISM-PLUS Study Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2001.113994_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0002-9149(99)00049-1","article-title":"Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes","volume":"83","author":"Alexander","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2001.113994_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/01.CIR.92.7.1743","article-title":"Previous aspirin use may attenuate the severity of the manifestations of acute coronary syndromes","volume":"92","author":"Garcia Dorado","year":"1995","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301437483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870301437483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:24:36Z","timestamp":1557383076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870301437483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0002870301437483"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2001.113994","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}